Schedule 13D ownership disclosure

Standard BioTools Inc

Common Stock, par value $0.001 per share · CUSIP: 34385P108

Event date: 2025-02-28

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Casdin Capital, LLCReported CIK 0001534261

    Shares: 76,075,636.00 · Class: 20.4%

  • Casdin Private Growth Equity Fund II, L.P.Reported CIK 0001891102

    Shares: 13,939,637.00 · Class: 3.7%

  • Casdin Private Growth Equity Fund II GP, LLCReported CIK 0001919480

    Shares: 13,939,637.00 · Class: 3.7%

  • Casdin Partners Master Fund, L.P.Reported CIK 0001534265

    Shares: 59,391,780.00 · Class: 15.9%

  • Casdin Partners GP, LLCReported CIK 0001534260

    Shares: 59,391,780.00 · Class: 15.9%

  • Eli CasdinReported CIK 0001534264

    Shares: 80,864,315.00 · Class: 21.6%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000919574-25-001773
Form type
SCHEDULE 13D/A
Filer
Casdin Capital, LLC
CIK
CIK 1534261
Filed
Mar 04, 2025
Reporting period
Feb 28, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub